REQUEST A DEMO
Total
USD $0.00
Search more companies

R-Farm AO (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: R-Farm AO Profile Updated: December 07, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

R-Farm AO is a reliable partner in the Russian pharmaceutical market for many leading global manufacturers in various areas, including research and development, technology transfer, market introduction of innovative drugs, and production localization. The company's strategy for successful partnerships is based on mutually beneficial cooperation, fulfilling commitments and goals, result-oriented approach, effective collaboration at all stages, and highly qualified staff.

Headquarters
Ulitsa Berzarina, Dom 19, Korpus 1
Moscow; Moscow; Postal Code: 123154

Contact Details: Purchase the R-Farm AO report to view the information.

Website: http://rpharm.ru

Basic Information
Total Employees:
Purchase the R-Farm AO report to view the information.
Outstanding Shares:
Purchase the R-Farm AO report to view the information.
Registered Capital:
Purchase the R-Farm AO report to view the information.
Financial Auditors:
Purchase the R-Farm AO report to view the information.
Incorporation Date:
August 17, 2001
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Ortat AO
100%
R-Farm Ms OOO
100%
R-Farm Mt OOO
100%
Company Performance
Financial values in the chart are available after R-Farm AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-12.53%
Total operating revenue
-12.53%
Operating profit (EBIT)
-36.4%
Net Profit (Loss) for the Period
-58.43%
Total assets
-2.04%
Total equity
24.86%
Operating Profit Margin (ROS)
-6.11%
Net Profit Margin
-8.05%
Return on Equity (ROE)
-39.89%
Debt to Equity Ratio
-6.61%
Quick Ratio
0.07%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?